دورية أكاديمية

Association of CYP2C19, CYP2D6 and CYP3A4 Genetic Variants on Primaquine Hemolysis in G6PD-Deficient Patients.

التفاصيل البيبلوغرافية
العنوان: Association of CYP2C19, CYP2D6 and CYP3A4 Genetic Variants on Primaquine Hemolysis in G6PD-Deficient Patients.
المؤلفون: Macêdo MM; Programa de Pós-graduação em Ciências Aplicadas à Hematologia, Universidade do Estado do Amazonas, Manaus 69040-000, AM, Brazil., Almeida ACG; Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus 69040-000, AM, Brazil.; Programa de Pós-graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus 69040-000, AM, Brazil., Silva GS; Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus 69040-000, AM, Brazil.; Programa de Pós-graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus 69040-000, AM, Brazil., Oliveira AC; Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus 69040-000, AM, Brazil.; Programa de Pós-graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus 69040-000, AM, Brazil., Mwangi VI; Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus 69040-000, AM, Brazil.; Programa de Pós-graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus 69040-000, AM, Brazil., Shuan AC; Programa de Pós-graduação em Ciências Aplicadas à Hematologia, Universidade do Estado do Amazonas, Manaus 69040-000, AM, Brazil.; Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus 69040-000, AM, Brazil., Barbosa LRA; Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus 69040-000, AM, Brazil.; Programa de Pós-graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus 69040-000, AM, Brazil., Rodrigues-Soares F; Departamento de Patologia, Genética e Evolução, Instituto de Ciências Biológicas e Naturais, Universidade Federal do Triângulo Mineiro, Uberaba 35025-250, MG, Brazil., Melo GC; Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus 69040-000, AM, Brazil.; Programa de Pós-graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus 69040-000, AM, Brazil.
المصدر: Pathogens (Basel, Switzerland) [Pathogens] 2023 Jun 30; Vol. 12 (7). Date of Electronic Publication: 2023 Jun 30.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101596317 Publication Model: Electronic Cited Medium: Print ISSN: 2076-0817 (Print) Linking ISSN: 20760817 NLM ISO Abbreviation: Pathogens Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI AG, 2012-
مستخلص: In the Amazon, the treatment for Plasmodium vivax is chloroquine plus primaquine. However, this regimen is limited due to the risk of acute hemolytic anemia in glucose-6-phosphate dehydrogenase deficiency. Primaquine is a prodrug that requires conversion by the CYP2D6 enzyme to be effective against malaria. A series of cases were performed at an infectious diseases reference hospital in the Western Brazilian Amazon. The STANDARD G6PD (SD Biosensor ® ) assay was used to infer G6PD status and real-time PCR to genotype G6PD, CYP2C19 , CYP2D6 and CYP3A4. Eighteen patients were included, of which 55.6% had African A- variant (G202A/A376G), 11.1% African A+ variant (A376G), 5.6% Mediterranean variant (C563T) and 27.8% were wild type. CYP2C19, CYP2D6 and CYP3A4 genotyping showed no statistically significant differences in the frequency of star alleles between the groups G6PD deficient and G6PD normal. Elevated levels of liver and kidney markers in the G6PDd patients were observed in gNM, gRM and gUM of CYP2C19 and CYP2D6 ( p < 0.05). Furthermore, in this study there was no influence of CYPs on hemolysis. These findings reinforce the importance of studies on the mapping of G6PD deficiency and genetic variations of CYP2C19, CYP2D6 and CYP3A4. This mapping will allow us to validate the prevalence of CYPs and determine their influence on hemolysis in patients with malaria, helping to decide on the treatment regimen.
References: Malar J. 2017 Jun 15;16(1):253. (PMID: 28619120)
PLoS Negl Trop Dis. 2022 Dec 12;16(12):e0010986. (PMID: 36508454)
Pharmacogenomics J. 2018 Dec;18(6):749-759. (PMID: 29713005)
Hematol Oncol Clin North Am. 2016 Apr;30(2):373-93. (PMID: 27040960)
PLoS One. 2014 Oct 20;9(10):e110691. (PMID: 25329392)
Clin Infect Dis. 2016 May 1;62(9):1188. (PMID: 26826373)
Front Pharmacol. 2022 Nov 15;13:752314. (PMID: 36457706)
Clin Infect Dis. 2019 Sep 27;69(8):1440-1442. (PMID: 30753364)
Lancet Glob Health. 2017 Oct;5(10):e1038-e1046. (PMID: 28867401)
Blood. 2020 Sep 10;136(11):1225-1240. (PMID: 32702756)
Malar J. 2018 Nov 8;17(1):415. (PMID: 30409136)
Genet Mol Biol. 2009 Apr;32(2):251-4. (PMID: 21637675)
Malar J. 2018 Mar 2;17(1):101. (PMID: 29499733)
Genet Med. 2017 Jan;19(1):69-76. (PMID: 27388693)
Rev Lat Am Enfermagem. 2019 Mar 18;27:e3111. (PMID: 30916225)
Am J Trop Med Hyg. 2008 May;78(5):736-40. (PMID: 18458306)
Clin Transl Sci. 2020 Jan;13(1):116-124. (PMID: 31647186)
Clin Microbiol Rev. 2019 Jul 31;32(4):. (PMID: 31366609)
Pharmgenomics Pers Med. 2020 Jan 10;13:1-12. (PMID: 32021383)
Front Pharmacol. 2021 Nov 26;12:784909. (PMID: 34899347)
Pharmacol Ther. 2016 May;161:1-10. (PMID: 27016470)
PLoS Med. 2012;9(11):e1001339. (PMID: 23152723)
Pharmacogenomics. 2017 May;18(7):701-739. (PMID: 28480783)
Lancet Reg Health Am. 2022 May 26;12:100273. (PMID: 36776424)
PLoS Negl Trop Dis. 2018 Apr 19;12(4):e0006230. (PMID: 29672516)
Malar J. 2019 Oct 7;18(1):340. (PMID: 31590661)
Mem Inst Oswaldo Cruz. 2014 Aug;109(5):553-68. (PMID: 25141282)
Adv Parasitol. 2013;81:133-201. (PMID: 23384623)
Clin Pharmacol Ther. 2020 Jan;107(1):154-170. (PMID: 31544239)
Trans R Soc Trop Med Hyg. 2013 May;107(5):301-6. (PMID: 23479361)
فهرسة مساهمة: Keywords: CYP2C19; CYP2D6; CYP3A4; G6PD deficiency; Plasmodium vivax; malaria; primaquine hemolysis
تواريخ الأحداث: Date Created: 20230729 Latest Revision: 20230801
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC10384057
DOI: 10.3390/pathogens12070895
PMID: 37513742
قاعدة البيانات: MEDLINE
الوصف
تدمد:2076-0817
DOI:10.3390/pathogens12070895